Cellular fats and cultured lipids

01Overview and value chain#

Markers EC: USDA/FDA joint regulatory framework for cell-cultured animal products | OECD: Food systems | Regulator: FDA (USA)

Cellular fats and cultured lipids grow actual animal adipose-derived cells — not a fermenting microbe standing in for animal fat — to produce a cultivated fat ingredient that blends into hybrid meat and plant-based products. Mission Barns won USDA and FDA sign-off for cultivated pork fat in 2025 and is targeting a Sprouts Farmers Market launch, using a proprietary bioreactor design intended to lower the capital intensity that has slowed whole-cut cultivated meat. Because fat cells are used as a flavor- and texture-carrying ingredient rather than a full-tissue meat replacement, the category needs far less structural scaffolding than whole-muscle cultivated meat, and academic groups have demonstrated proof-of-concept adipose-derived stem cell fat production from both bovine and duck cell lines in 3D culture. The category has already produced its own cautionary tale: CellulaREvolution, a UK originator working on bovine adipose-derived stem cell spheroids as building blocks for cultured fat, entered administration, with its IP and assets put up for sale.

Key directions of cellular fats and cultured lipids:

1. Cultivated pork/duck fat (Cultivated Pork/Duck Fat): adipose-derived cells grown and harvested specifically as a fat ingredient for blended meat products, proven at lab scale for both pork and duck cell lines.
2. Ingredient-scale cell culture (Ingredient-Scale Cell Culture): fat cells cultured as a flavor/texture additive rather than attempting a full structural meat replacement, lowering the scaffolding and bioreactor burden versus whole-cut cultivated meat.
3. Novel bioreactor engineering for fat cells (Novel Bioreactor Engineering for Fat Cells): purpose-built, more easily scaled bioreactor designs specifically targeting fat-cell culture economics rather than adapting muscle-cell bioreactors.
4. 3D spheroid biofabrication (3D Spheroid Biofabrication): building cultured fat from dynamically cultured, differentiated adipose-derived stem cell spheroids as a structural building block.

Sectoral value chain#

[cell line sourcing] ──> [growth-media formulation] ──> [bioreactor cultivation] ──> [fat harvest & processing]
                                                                 │
                                                         (regulatory
                                                          clearance)
                                                                 │
                                                                 ▼
[hybrid meat product] <─── [ingredient blending] <──────────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Adipose-derived stem cell isolation (Adipose-Derived Stem Cell Isolation): sourcing and banking the target species’ fat-precursor cells as the production cell line.
• 3D spheroid culture (3D Spheroid Culture): growing differentiated adipose-derived cells as spheroids to serve as building blocks for structured cultured fat.
• Purpose-built fat-cell bioreactors (Purpose-Built Fat-Cell Bioreactors): bioreactor designs engineered specifically around fat-cell (rather than muscle-cell) culture economics.

02US#

The US hosts the sector’s first regulatory-cleared cultivated fat product and a second cell-agriculture originator founded by an early cultivated-meat tissue-engineering researcher.

USDA/FDA joint sign-off, novel bioreactor scale-up, cultivated-meat tissue-engineering pedigree#

• Mission Barns: won USDA and FDA sign-off for cultivated pork fat in 2025, developed a novel, more easily scaled bioreactor design, and is targeting a retail launch through Sprouts Farmers Market.
• Ohayo Valley: founded by Dr. Jess Krieger, one of the first researchers in the world to pursue a PhD specifically on cultivated meat tissue engineering, extending that research background into a cell-agriculture venture.

03CN#

Public information on a dedicated Chinese cellular-fat/cultured-lipid originator was not confirmed in this pass; the section stays at the policy level.

no confirmed flagship originator, adjacent fermentation-fat investment, regulatory framework absent#

• No confirmed flagship originator: a Chinese company operating a true animal-cell-culture fat platform (as opposed to microbial-fermentation fat production) was not confirmed via live sources in this pass.
• Adjacent fermentation-fat activity: Chinese fermentation specialists have partnered with overseas precision-fermentation fat originators, reflecting capacity and investment interest in fat alternatives generally, without a confirmed domestic cell-culture originator.
• No dedicated regulatory framework: unlike the US’s USDA/FDA joint review pathway, no China-specific cell-cultured-fat authorization framework was confirmed in this pass.

04EU#

The EU/UK region shows both a growing cell-cultured-fat originator raising early funding and a cautionary example of one going into administration.

Berlin-based cultured-fat funding, UK spheroid biofabrication research, insolvency risk in early-stage cell agriculture#

• Cultimate Foods: a Berlin-based originator (founded 2022) specializing in cultivating animal fat as an ingredient to improve the flavor and quality of plant-based meat, which raised €2.3 million to develop its fat ingredient.
• CellulaREvolution: a UK originator that developed dynamically cultured, differentiated bovine adipose-derived stem cell spheroids as building blocks for biofabricating cultured fat, but entered administration, with its IP and assets subsequently put up for sale.
• Early-stage capital risk: the sector’s UK example illustrates that cell-culture-based fat ventures carry meaningful insolvency risk at the pre-commercial research stage, distinct from the demand-side risk seen in industrial insect farming.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack is built around culturing fat cells as an ingredient rather than a structural meat substitute.

1. Purpose-built fat-cell bioreactors (Purpose-Built Fat-Cell Bioreactors):
   • bioreactor designs are engineered specifically around fat-cell culture economics rather than adapted from muscle-cell systems.
   • case: Mission Barns’ novel bioreactor design is intended to lower the capital intensity that has slowed broader cultivated-meat scale-up.
2. 3D adipose spheroid biofabrication (3D Adipose Spheroid Biofabrication):
   • differentiated adipose-derived stem cells are dynamically cultured as spheroids that serve as structural building blocks for cultured fat.
   • case: bovine adipose-derived stem cell spheroids have been demonstrated as a biofabrication building block in peer-reviewed research.
3. Cross-species proof-of-concept culture (Cross-Species Proof-of-Concept Culture):
   • fat-cell culture methods are being validated across multiple species’ cell lines rather than a single target animal.
   • case: proof-of-concept cell-culture-based duck fat production has been demonstrated at laboratory scale alongside bovine and porcine work.

07Value chains and production pipelines#

Industrial pipeline of a cultivated fat ingredient (USDA/FDA joint pre-market review)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Cell line sourcing     │ ───> │ 2. Media formulation      │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Regulatory dossier     │ <─── │ 3. Bioreactor cultivation │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Ingredient blending    │ ───> │ 6. Retail launch          │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Cell line sourcing

Adipose-derived stem cells are isolated and banked from the target species (pig, cattle, duck).

Stage 2: Media formulation

A serum-free growth medium is formulated to expand and differentiate the fat-precursor cells.

Stage 3: Bioreactor cultivation

Cells or spheroids are cultured at scale in a purpose-built bioreactor designed around fat-cell economics.

Stage 4: Regulatory dossier

A joint USDA/FDA pre-market safety dossier is filed and reviewed, as completed by Mission Barns in 2025.

Stage 5: Ingredient blending

The cleared cultivated fat is blended into a hybrid meat or plant-based product to carry flavor and texture.

Stage 6: Retail launch

The finished product reaches retail, as targeted through a named grocery partner in the sector’s first cleared case.